8955160 |
Identification and characterization of CD39/vascular ATP diphosphohydrolase
Anrather, J,
Robson, SC,
Sévigny, J,
Beaudoin, AR,
Siegel, JB,
Koziak, K,
Bach, FH,
Kaczmarek, E
|
J Biol Chem |
1996 |
18404504 |
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8
Lavoie, EG,
Lévesque, SA,
Sévigny, J,
Kukulski, F,
Kirley, TL,
Robson, SC,
Bigonnesse, F,
Lecka, J,
Knowles, AF
|
Purinergic Signal. |
2005 |
21586362 |
Impact of ectoenzymes on p2 and p1 receptor signaling
Sévigny, J,
Kukulski, F,
Lévesque, SA
|
Adv. Pharmacol. |
2011 |
11927941 |
CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness
Sévigny, J,
Takashima, A,
Kumamoto, T,
Robson, SC,
Mizumoto, N,
Matsue, H,
Enjyoji, K
|
Nat. Med. |
2002 |
19640930 |
NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse
Kauffenstein, G,
Sévigny, J,
Thorin-Trescases, N,
Robaye, B,
D'Orléans-Juste, P,
Drouin, A,
Marceau, F,
Bachelard, H,
Thorin, E
|
Cardiovasc. Res. |
2010 |
10470077 |
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
Lech, M,
Frenette, PS,
Csizmadia, E,
Rosenberg, RD,
Imai, M,
Lin, Y,
Enjyoji, K,
Robson, SC,
Wagner, DD,
Sévigny, J,
Edelberg, JM,
Esch, JS,
Christie, PD,
Rayburn, H,
Beeler, DL
|
Nat. Med. |
1999 |
10866813 |
Distribution, cloning, and characterization of porcine nucleoside triphosphate diphosphohydrolase-1
Vanduffel, L,
Beaudoin, AR,
Benrezzak, O,
Sévigny, J,
Lemmens, R,
Kittel, A
|
Eur. J. Biochem. |
2000 |
17502665 |
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Chen, JF,
Strom, TB,
Friedman, D,
Dwyer, KM,
Deaglio, S,
Usheva, A,
Oukka, M,
Enjyoji, K,
Gao, W,
Robson, SC,
Erat, A,
Kuchroo, VK,
Linden, J
|
J. Exp. Med. |
2007 |